Back to Search
Start Over
Rosiglitazone restores nitric oxide synthase‐dependent reactivity of cerebral arterioles in rats exposed to prenatal alcohol
- Source :
- Alcoholism: Clinical and Experimental Research. 45:1359-1369
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- BACKGROUND Prenatal exposure to alcohol leads to a greater incidence of many cardiovascular-related diseases, presumably via a mechanism that may involve increased oxidative stress. An agonist of peroxisome proliferator-activated receptor gamma (PPARγ; rosiglitazone) has been shown to suppress alcohol-induced neuroinflammation and oxidative stress. The goal of this study was to determine whether acute and chronic treatment with rosiglitazone could restore or prevent impaired nitric oxide synthase (NOS)-dependent responses of cerebral arterioles in male and female adult (14-16 weeks old) rats exposed to alcohol in utero. METHODS We fed Sprague-Dawley dams a liquid diet with or without 3% ethanol for the duration of their pregnancy (21-23 days). In the first series of studies, we examined the reactivity of cerebral arterioles to eNOS- (ADP), nNOS-dependent (NMDA), and NOS-independent agonists in male and female adult rats before and during acute (1 hour) topical application of rosiglitazone (1 µM). In a second series of studies, we examined the influence of chronic treatment with rosiglitazone (3 mg/kg/day in drinking water for 2-3 weeks) on the responses of cerebral arterioles in male and female adult rats exposed to alcohol in utero. RESULTS We found that in utero exposure to alcohol similarly reduced responses of cerebral arterioles to ADP and NMDA, but not to nitroglycerin in male and female adult rats. In addition, acute treatment of the male and female adult rats with rosiglitazone similarly restored this impairment in cerebral vascular function to that observed in controls. We also found that chronic treatment with rosiglitazone prevented impaired vascular function in male and female adult rats that were exposed to alcohol in utero. CONCLUSIONS PPARγ activation may be an effective and relevant treatment to reverse or prevent cerebral vascular abnormalities associated with prenatal exposure to alcohol.
- Subjects :
- Male
Agonist
medicine.medical_specialty
medicine.drug_class
Fetal alcohol syndrome
030508 substance abuse
Medicine (miscellaneous)
Toxicology
medicine.disease_cause
Nitric oxide
Rats, Sprague-Dawley
Rosiglitazone
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Pregnancy
Superoxides
Enos
Internal medicine
medicine
Animals
Ethanol
biology
business.industry
Brain
biology.organism_classification
medicine.disease
Rats
PPAR gamma
Nitric oxide synthase
Arterioles
Cerebrovascular Disorders
Oxidative Stress
Psychiatry and Mental health
Endocrinology
chemistry
In utero
Prenatal Exposure Delayed Effects
biology.protein
Female
Nitric Oxide Synthase
0305 other medical science
business
030217 neurology & neurosurgery
Oxidative stress
medicine.drug
Subjects
Details
- ISSN :
- 15300277 and 01456008
- Volume :
- 45
- Database :
- OpenAIRE
- Journal :
- Alcoholism: Clinical and Experimental Research
- Accession number :
- edsair.doi.dedup.....1f60871ba5e8bbe5eb1ee746d4cf4ea8
- Full Text :
- https://doi.org/10.1111/acer.14634